PT3217980T - Ciclopirox, ciclopirox olamina ou um pró-fármaco de ciclopirox para utilização no tratamento de cancro da bexiga - Google Patents

Ciclopirox, ciclopirox olamina ou um pró-fármaco de ciclopirox para utilização no tratamento de cancro da bexiga

Info

Publication number
PT3217980T
PT3217980T PT158592683T PT15859268T PT3217980T PT 3217980 T PT3217980 T PT 3217980T PT 158592683 T PT158592683 T PT 158592683T PT 15859268 T PT15859268 T PT 15859268T PT 3217980 T PT3217980 T PT 3217980T
Authority
PT
Portugal
Prior art keywords
ciclopirox
methods
prodrug
bladder cancer
cancer treatment
Prior art date
Application number
PT158592683T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Univ Kansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kansas filed Critical Univ Kansas
Publication of PT3217980T publication Critical patent/PT3217980T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT158592683T 2014-11-11 2015-11-10 Ciclopirox, ciclopirox olamina ou um pró-fármaco de ciclopirox para utilização no tratamento de cancro da bexiga PT3217980T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462078069P 2014-11-11 2014-11-11
US201562134747P 2015-03-18 2015-03-18

Publications (1)

Publication Number Publication Date
PT3217980T true PT3217980T (pt) 2020-12-11

Family

ID=55954945

Family Applications (1)

Application Number Title Priority Date Filing Date
PT158592683T PT3217980T (pt) 2014-11-11 2015-11-10 Ciclopirox, ciclopirox olamina ou um pró-fármaco de ciclopirox para utilização no tratamento de cancro da bexiga

Country Status (12)

Country Link
US (1) US20170304329A1 (enExample)
EP (1) EP3217980B1 (enExample)
JP (1) JP2017533952A (enExample)
CN (2) CN116687941A (enExample)
DK (1) DK3217980T3 (enExample)
ES (1) ES2836208T3 (enExample)
HR (1) HRP20201893T1 (enExample)
HU (1) HUE052670T2 (enExample)
PL (1) PL3217980T3 (enExample)
PT (1) PT3217980T (enExample)
RS (1) RS61222B1 (enExample)
WO (1) WO2016077346A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11753379B2 (en) 2018-05-30 2023-09-12 Clariant International Ltd Process for forming 2-hydroxypyridine-1-oxide or derivatives thereof
CN113194945B (zh) * 2018-08-23 2024-07-23 佩勒梅德有限公司 环吡酮的抑制hbv核心组装的用途
WO2021078937A1 (en) * 2019-10-25 2021-04-29 Deutsches Krebsforschungszentrum Treatment of stat3 related diseases by iron chelators
EP4193989A1 (en) 2021-12-09 2023-06-14 Atlas Molecular Pharma, S.L. A formulation for an effective oral administration of ciclopirox with no adversal gasterointestinal toxicity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU754965B2 (en) 1997-12-31 2002-11-28 University Of Kansas, The Water soluble prodrugs of tertiary amine containing drugs and methods of making thereof
AU2003251875A1 (en) * 2002-07-15 2004-02-02 Combinatorx, Incorporated Combination therapy for the treatment of neoplasms
WO2010048712A1 (en) 2008-10-31 2010-05-06 University Health Network Ciclopirox and cytarabine for the treatment of leukemic disorders
WO2011153197A1 (en) * 2010-06-01 2011-12-08 Biotheryx, Inc. Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases
PL2646035T3 (pl) * 2010-12-02 2016-08-31 Univ Kansas Proleki 6-cykloheksylo-1-hydroksy-4-metylopirydyn-2(1h)-onu i ich pochodne

Also Published As

Publication number Publication date
DK3217980T3 (da) 2020-12-07
EP3217980A4 (en) 2018-05-02
RS61222B1 (sr) 2021-01-29
HRP20201893T1 (hr) 2021-02-05
ES2836208T3 (es) 2021-06-24
HUE052670T2 (hu) 2021-05-28
US20170304329A1 (en) 2017-10-26
WO2016077346A1 (en) 2016-05-19
CN107206012A (zh) 2017-09-26
JP2017533952A (ja) 2017-11-16
CN116687941A (zh) 2023-09-05
EP3217980B1 (en) 2020-10-14
PL3217980T3 (pl) 2021-03-22
EP3217980A1 (en) 2017-09-20

Similar Documents

Publication Publication Date Title
ZA201702382B (en) Combination therapy for cancer
SMT202100115T1 (it) Combinazioni di inibitori di fgfr e cmet per il trattamento del cancro
IL250387A0 (en) combined treatment
IL259996A (en) Combinations for cancer treatment
IL249898A0 (en) Combined cancer treatment
GB201405033D0 (en) Combination therapy
PT3020430T (pt) Cânula para terapia de implantação de sutura catgut
IL247859A0 (en) Cancer treatment
IL246761A0 (en) Combined cancer treatment
ZA201804155B (en) Combination therapy
GB201408297D0 (en) Treatment of cancer
EP3217980A4 (en) Methods of bladder cancer treatment with ciclopirox, ciclopirox olamine, or a ciclopirox prodrug
GB201409363D0 (en) Skin cancer treatment
GB201522433D0 (en) Cancer treatment
ZA201608217B (en) Combination therapy
SG11201606296YA (en) Safe catheter
GB201407837D0 (en) Methods of cancer therapy
EP3270898A4 (en) Methods for the treatment of bladder cancer
GB201417456D0 (en) Treatment of cancer
GB201411884D0 (en) Cancer therapy
GB201411570D0 (en) Therapy
GB201408210D0 (en) Therapy
GB201417994D0 (en) Anticancer treatments
GB201414353D0 (en) Anticancer treatments
GB201412270D0 (en) Finishing treatment